WFI grade water for pharmaceuticals
Domestic manufacturing, stable procurement, and transportation cost reduction! Providing WFI-grade water ideal for pharmaceutical manufacturing.
In the pharmaceutical industry, the purity of the water used in manufacturing is extremely important to ensure the quality of pharmaceuticals. In particular, water that meets the standards for injection is essential for guaranteeing the safety and efficacy of products. Contamination with impurities can lead to a deterioration in product quality and pose health risks to patients. Our WFI-grade water is produced in a GMP-compliant manufacturing environment and has passed the quality tests of the Japanese Pharmacopoeia. This ensures that it meets high-quality standards in pharmaceutical manufacturing, allowing for safe use. 【Usage Scenarios】 - Preparation of culture media in pharmaceutical manufacturing - Preparation of buffers 【Benefits of Implementation】 - Improvement in pharmaceutical quality - Streamlining of manufacturing processes - Compliance with regulations
basic information
【Features】 - GMP-compliant manufacturing environment - Quality testing in accordance with the Japanese Pharmacopoeia - Certificate of analysis included - Customization available for bag capacity, tubes, and connectors - Colorless, clear, and odorless 【Our Strengths】 We provide contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, all in compliance with GMP. Leveraging years of experience and advanced technology, we deliver high-quality products tailored to our customers' needs.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■ Medium preparation ■ Buffer preparation ■ Washing *For more details, please download the PDF or feel free to contact us.
catalog（3）
Download All Catalogs
Recommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.